Patents by Inventor Laure Françoise Valérie Navarre

Laure Françoise Valérie Navarre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of synthesizing enantiopure deuterium-enriched pioglitazone
    Patent number: 11767317
    Abstract: The invention provides methods of synthesis of enantiopure deuterium enriched R-pioglitazone with structure of compound (IV), or a pharmaceutically acceptable salt thereof: The invention further provides chemical intermediates useful in the synthesis of compound (IV), and methods of synthesizing those intermediates.
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: September 26, 2023
    Assignee: Poxel SA
    Inventors: Laure Françoise Valérie Navarre, Vincent Jacques, Sébastien Bolze
  • CRYSTALLINE FORMS OF DEUTERIUM-ENRICHED PIOGLITAZONE
    Publication number: 20230074827
    Abstract: Provided herein are crystalline forms of deuterium-enriched (R)-pioglitazone and compositions thereof. Also provided herein are methods of using the crystalline forms of deuterium-enriched (R)-pioglitazone and compositions thereof.
    Type: Application
    Filed: March 31, 2022
    Publication date: March 9, 2023
    Inventors: Laure Françoise Valérie Navarre, Emeline Gardette, Sébastien Bolze, Sheila DeWitt, Vincent Jacques
  • Crystalline forms of deuterium-enriched pioglitazone
    Patent number: 11319313
    Abstract: Provided herein are crystalline forms of deuterium-enriched (R)-pioglitazone and compositions thereof. Also provided herein are methods of using the crystalline forms of deuterium-enriched (R)-pioglitazone and compositions thereof.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: May 3, 2022
    Assignee: Poxel SA
    Inventors: Laure Françoise Valérie Navarre, Emeline Gardette, Sébastien Bolze, Sheila DeWitt, Vincent Jacques
  • CRYSTALLINE FORMS OF DEUTERIUM-ENRICHED PIOGLITAZONE
    Publication number: 20210403464
    Abstract: Provided herein are crystalline forms of deuterium-enriched (R)-pioglitazone and compositions thereof. Also provided herein are methods of using the crystalline forms of deuterium-enriched (R)-pioglitazone and compositions thereof.
    Type: Application
    Filed: May 7, 2021
    Publication date: December 30, 2021
    Inventors: Laure Françoise Valérie Navarre, Emeline Gardette, Sébastien Bolze, Sheila DeWitt, Vincent Jacques